Cargando…
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
Cefiderocol is a new siderophore cephalosporin approved for the treatment of multidrug resistant bacteria including activity against carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa. As cephalosporins are known for their high pharmacokinetic variability in critically ill patients, ce...
Autores principales: | Zimmer, Julia, Röhr, Anka C., Kluge, Stefan, Faller, Jonas, Frey, Otto R., Wichmann, Dominic, König, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997268/ https://www.ncbi.nlm.nih.gov/pubmed/33670891 http://dx.doi.org/10.3390/antibiotics10030242 |
Ejemplares similares
-
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin
por: Chiriac, Ute, et al.
Publicado: (2022) -
Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
por: König, Christina, et al.
Publicado: (2021) -
Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
por: König, Christina, et al.
Publicado: (2021) -
Evaluation of the clinical and quantitative performance of a practical HPLC-UV platform for in-hospital routine therapeutic drug monitoring of multiple drugs
por: Morikawa, Go, et al.
Publicado: (2023) -
Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
por: Bianco, Gabriele, et al.
Publicado: (2023)